L.A. 20% Oxytetracycline Injection
Video
Composition
Appearance: The solution should be yellow to light brown clear liquid.
Composition
1 ml of L.A. Oxytetracycline injection 20% contains Oxytetracycline dihydrate equal to 200 mg base.
Indication
The use of tetracycline is indicated in systemic and local infections such as Bronchopneumon ia, bacterial enteritis, urinary tract infections, cholang itis, Metrit1s, mastitis, pyodermia,Anthrax, Diphtheria and CRD.
Specific indications for sheep, Goat & Cattle are respiratory infections, mastitis, metrit1s, chlamyd iosis, and infections of the cornea, conjunctiva and wound infection
Specific indications for poultry are chronic respiratory disease (CRD) Colibacillosis and fowl cholera
Dosage and administration
The general dose is: 10-20mg/kg body weight, daily. Adult: 0.5ml/10kg, young animals 1ml/ 10kg body weight Cattle, camel, sheep, goats: a single injection at a dose of 20 mg oxytetracycline per kg of body weight or 1 ml per 10 kg body weight
Administration route
intramuscular injection
Dosage interval
Repeat the second Injection after 2-4 days
Toxicology
Acute effects due to the use of tetracycline are not often observed
Adverse effects
Adverse effects due to the use of tetracycline are: allergic reactions, photosensitivity, discoloration of teeth on young age group and hepatoxicity, oxytetracycline can also cause tissue irritation at the site of injection
Contra indication
A contra-indication for the use of tetracycline is the severe liver or kidney damage and occasional hypersensitivity to tetracycline
Therapeutic incom patibilities
Tetracycline should not be combined with bactericidal antibiotics such as penicill1nes, cephalosporins. The absorption of tetracycline is inhibited when given concomitantly with preparations containing divalent cations. Combination of tetracycline with macrolides such as tylosin and polymyxins such as colistin, works synergistically
Advised withdrawal period
Meats: 21 days
Milk,Eggs: 07 days
Remarks
Store below 25℃, protect from light. Keep out of reach of children. Do not use if the solution becomes turbid or blackish. Always consult your veterinarian before using the drug
Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation based veterinary enterprise, there are 65 technical professionals. Veyong has two production bases: Shijiazhuang and Ordos, of which the Shijiazhuang base covers an area of 78,706 m2, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 11 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own- label preparations, and OEM & ODM service.
Veyong attaches great importance to the management of EHS(Environment, Health& Safety) system, and obtained the ISO14001 and OHSAS18001 certificates. Veyong has been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply of products.
Veyong established the complete quality management system, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technical service, our company has gained reliance and support from numerous customers by excellent product quality, high-quality pre-sales and after-sales service, serious and scientific management. Veyong has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.